Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study
Background. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significan...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2013/518945 |
id |
doaj-0ec9bbfccd104cc8a74bc8e1a48e04c6 |
---|---|
record_format |
Article |
spelling |
doaj-0ec9bbfccd104cc8a74bc8e1a48e04c62020-11-24T23:18:41ZengHindawi LimitedDisease Markers0278-02401875-86302013-01-0135679179810.1155/2013/518945518945Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up StudyMaria do Sameiro-Faria0Sandra Ribeiro1Elísio Costa2Denisa Mendonça3Laetitia Teixeira4Petronila Rocha-Pereira5João Fernandes6Henrique Nascimento7Michaela Kohlova8Flávio Reis9Leonilde Amado10Elsa Bronze-da-Rocha11Vasco Miranda12Alexandre Quintanilha13Luís Belo14Alice Santos-Silva15Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, PortugalInstituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalCentro Investigação Ciências Saúde, Universidade Beira Interior, Covilhã, PortugalCentro Investigação Ciências Saúde, Universidade Beira Interior, Covilhã, PortugalNephrocare Portugal, SA-Nephrocare Maia, Maia, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalNephrocare Portugal, SA-Nephrocare Maia, Maia, PortugalInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalLaboratório de Bioquímica, Departamento de Ciências Biológicas, Faculdade Farmácia, Universidade do Porto, Porto, PortugalBackground. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significant association of death with these disturbances, by performing a two-year follow-up study. Methods and Results. A large set of data was obtained from 189 HD patients (55.0% male; 66.4 ± 13.9 years old), including hematological data, lipid profile, iron metabolism, nutritional, inflammatory, and endothelial (dys)function markers, and dialysis adequacy. Results. 35 patients (18.5%) died along the follow-up period. Our data showed that the type of vascular access, C-reactive protein (CRP), and triglycerides (TG) are significant predictors of death. The risk of death was higher in patients using central venous catheter (CVC) (Hazard ratio [HR] =3.03, 95% CI = 1.49–6.13), with higher CRP levels (fourth quartile), compared with those with lower levels (first quartile) (HR = 17.3, 95% CI = 2.40–124.9). Patients with higher TG levels (fourth quartile) presented a lower risk of death, compared with those with the lower TG levels (first quartile) (HR = 0.18, 95% CI = 0.05–0.58). Conclusions. The use of CVC, high CRP, and low TG values seem to be independent risk factors for mortality in HD patients.http://dx.doi.org/10.1155/2013/518945 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maria do Sameiro-Faria Sandra Ribeiro Elísio Costa Denisa Mendonça Laetitia Teixeira Petronila Rocha-Pereira João Fernandes Henrique Nascimento Michaela Kohlova Flávio Reis Leonilde Amado Elsa Bronze-da-Rocha Vasco Miranda Alexandre Quintanilha Luís Belo Alice Santos-Silva |
spellingShingle |
Maria do Sameiro-Faria Sandra Ribeiro Elísio Costa Denisa Mendonça Laetitia Teixeira Petronila Rocha-Pereira João Fernandes Henrique Nascimento Michaela Kohlova Flávio Reis Leonilde Amado Elsa Bronze-da-Rocha Vasco Miranda Alexandre Quintanilha Luís Belo Alice Santos-Silva Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study Disease Markers |
author_facet |
Maria do Sameiro-Faria Sandra Ribeiro Elísio Costa Denisa Mendonça Laetitia Teixeira Petronila Rocha-Pereira João Fernandes Henrique Nascimento Michaela Kohlova Flávio Reis Leonilde Amado Elsa Bronze-da-Rocha Vasco Miranda Alexandre Quintanilha Luís Belo Alice Santos-Silva |
author_sort |
Maria do Sameiro-Faria |
title |
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study |
title_short |
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study |
title_full |
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study |
title_fullStr |
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study |
title_full_unstemmed |
Risk Factors for Mortality in Hemodialysis Patients: Two-Year Follow-Up Study |
title_sort |
risk factors for mortality in hemodialysis patients: two-year follow-up study |
publisher |
Hindawi Limited |
series |
Disease Markers |
issn |
0278-0240 1875-8630 |
publishDate |
2013-01-01 |
description |
Background. End-stage renal disease (ESRD) patients under hemodialysis (HD) have high mortality rate. Inflammation, dyslipidemia, disturbances in erythropoiesis, iron metabolism, endothelial function, and nutritional status have been reported in these patients. Our aim was to identify any significant association of death with these disturbances, by performing a two-year follow-up study. Methods and Results. A large set of data was obtained from 189 HD patients (55.0% male; 66.4 ± 13.9 years old), including hematological data, lipid profile, iron metabolism, nutritional, inflammatory, and endothelial (dys)function markers, and dialysis adequacy. Results. 35 patients (18.5%) died along the follow-up period. Our data showed that the type of vascular access, C-reactive protein (CRP), and triglycerides (TG) are significant predictors of death. The risk of death was higher in patients using central venous catheter (CVC) (Hazard ratio [HR] =3.03, 95% CI = 1.49–6.13), with higher CRP levels (fourth quartile), compared with those with lower levels (first quartile) (HR = 17.3, 95% CI = 2.40–124.9). Patients with higher TG levels (fourth quartile) presented a lower risk of death, compared with those with the lower TG levels (first quartile) (HR = 0.18, 95% CI = 0.05–0.58). Conclusions. The use of CVC, high CRP, and low TG values seem to be independent risk factors for mortality in HD patients. |
url |
http://dx.doi.org/10.1155/2013/518945 |
work_keys_str_mv |
AT mariadosameirofaria riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT sandraribeiro riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT elisiocosta riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT denisamendonca riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT laetitiateixeira riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT petronilarochapereira riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT joaofernandes riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT henriquenascimento riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT michaelakohlova riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT flavioreis riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT leonildeamado riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT elsabronzedarocha riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT vascomiranda riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT alexandrequintanilha riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT luisbelo riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy AT alicesantossilva riskfactorsformortalityinhemodialysispatientstwoyearfollowupstudy |
_version_ |
1725580583555301376 |